# Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)

> **NCT06166901** · NA · COMPLETED · sponsor: **Alcon Research** · enrollment: 211 (actual)

## Conditions studied

- Aphakia
- Astigmatism
- Presbyopia

## Interventions

- **DEVICE:** AcrySof IQ PanOptix IOL Toric
- **DEVICE:** AcrySof IQ PanOptix IOL Non-Toric

## Key facts

- **NCT ID:** NCT06166901
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-27
- **Primary completion:** 2025-02-05
- **Final completion:** 2025-02-05
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06166901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06166901, "Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06166901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*